MicroRNAs as the critical regulators of tyrosine kinase inhibitors resistance in lung tumor cells

Lung cancer is the second most common and the leading cause of cancer related deaths globally. Tyrosine Kinase Inhibitors (TKIs) are among the common therapeutic strategies in lung cancer patients, however the treatment process fails in a wide range of patients due to TKIs resistance. Given that the...

Descripción completa

Detalles Bibliográficos
Autores principales: Maharati, Amirhosein, Zanguei, Amir Sadra, Khalili-Tanha, Ghazaleh, Moghbeli, Meysam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905758/
https://www.ncbi.nlm.nih.gov/pubmed/35264191
http://dx.doi.org/10.1186/s12964-022-00840-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905758/
https://www.ncbi.nlm.nih.gov/pubmed/35264191
http://dx.doi.org/10.1186/s12964-022-00840-4

Ejemplares similares